| |
|
|
|
|
|
|
|||
|
KM Shannon, JW Larrick, SA Fulcher, KB Burck, J Pacely, JC Davis and DB Ring
The relative requirements of colonies derived from erythroid (BFU-E) and
myeloid (CFU-c) progenitors for transferrin were examined using monoclonal
antibodies directed against the transferrin molecule (TF-6) or its cell
surface receptor (TFR-A12, TFR1-2B). Growth of erythroid bursts was
profoundly reduced at concentrations of all three antibodies that had no
effect on CFU-c-derived colonies. When TFR1-2B was layered over cultures
established one to seven days previously, further burst development was
inhibited, and degeneration of early erythroid colonies was observed.
Addition of erythropoietin augmented transferrin receptor expression on
cells harvested after 1 to 2 weeks in culture and analyzed by flow
cytometry. Recombinant human erythropoietin gave results comparable to
those obtained in experiments using human urinary erythropoietin. Analysis
of erythroblasts plucked directly from culture plates confirmed the
presence of transferrin receptors on BFU-E-derived colonies. Thymidine
incorporation was maximal early in the second week of culture and coincided
with high transferrin receptor expression. These data demonstrate that
transferrin must be available into the second week of culture to support
the growth and differentiation of BFU- E-derived erythroid bursts, that the
generation of erythroid colonies from BFU-E is more dependent on
transferrin than myeloid colony formation from CFU-c, and that
erythropoietin modulates the expression of transferrin receptors on growing
bursts.
This article has been cited by other articles:
| |||||||||||
| Copyright © 1986 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||